World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
48
Citations
8241
World Ranking
18400
National Ranking
7512

Overview

Robert G. K. Donald is affiliated with Pfizer in the United States and has a research focus spanning biochemistry, genetics, molecular biology, and medicine. Their work covers several subfields including epidemiology, endocrinology, molecular medicine, infectious diseases, and microbiology. The primary research topics include Escherichia coli research studies, antibiotic resistance in bacteria, urinary tract infections management, pneumonia and respiratory infections, Enterobacteriaceae and Cronobacter research, bacterial infections and vaccines, as well as pediatric urology and nephrology studies.

Donald has contributed to multiple papers published in a variety of scientific journals. Some of the recent publications include:

  • Epidemiology of Invasive Escherichia coli Infection and Antibiotic Resistance Status Among Patients Treated in US Hospitals: 2009-2016, 2021, Clinical Infectious Diseases
  • Preclinical Immunogenicity and Efficacy of Optimized O25b O-Antigen Glycoconjugates To Prevent MDR ST131 E. coli Infections, 2022, Infection and Immunity
  • Horizontal Transmission of Cytomegalovirus in a Rhesus Model Despite High-Level, Vaccine-Elicited Neutralizing Antibody and T-Cell Responses, 2022, The Journal of Infectious Diseases
  • Semisynthetic Glycoconjugate Vaccine Candidates against Escherichia coli O25B Induce Functional IgG Antibodies in Mice, 2022, JACS Au
  • A cynomolgus monkey E. coli urinary tract infection model confirms efficacy of new FimH vaccine candidates, 2024, Infection and Immunity

Donald has collaborated frequently with several coauthors, including Annaliesa S. Anderson, Laurent Chorro, Arthur Illenberger, Srinivas Kodali, and David Keeney. The collaborations reflect a consistent research effort in infectious diseases and vaccine development.

Thevenues where Donald's work is most frequently published highlight a focus on infection and immunity as well as molecular and clinical infectious diseases. Leading publication venues include Infection and Immunity, bioRxiv (Cold Spring Harbor Laboratory), Clinical Infectious Diseases, The Journal of Infectious Diseases, and JACS Au.

Best Publications

  • Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum

    Ross F. Waller;Patrick J. Keeling;Robert G. K. Donald;Boris Striepen

  • Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii.

    Roos Ds;Donald Rg;Morrissette Ns;Moulton Al

  • Insertional tagging, cloning, and expression of the Toxoplasma gondii hypoxanthine-xanthine-guanine phosphoribosyltransferase gene. Use as a selectable marker for stable transformation.

    Robert G.K. Donald;Darrick Carter;Buddy Ullman;David S. Roos

  • Mutation of either G box or I box sequences profoundly affects expression from the Arabidopsis rbcS‐1A promoter.

    R. G. K. Donald;A. R. Cashmore

  • Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria.

    Robert G. K. Donald;David S. Roos

  • INSERTIONAL MUTAGENESIS AND MARKER RESCUE IN A PROTOZOAN PARASITE : CLONING OF THE URACIL PHOSPHORIBOSYLTRANSFERASE LOCUS FROM TOXOPLASMA GONDII

    Robert G. K. Donald;David S. Roos

  • Origin, targeting, and function of the apicomplexan plastid

    David S Roos;Michael J Crawford;Robert Gk Donald;Jessica C Kissinger

  • Discovery of Kibdelomycin, A Potent New Class of Bacterial Type II Topoisomerase Inhibitor by Chemical-Genetic Profiling in Staphylococcus aureus

    John W. Phillips;Michael A. Goetz;Scott K. Smith;Deborah L. Zink

  • Purification and molecular characterization of cGMP-dependent protein kinase from Apicomplexan parasites. A novel chemotherapeutic target.

    Anne M. Gurnett;Paul A. Liberator;Paula M. Dulski;Scott P. Salowe

  • A role for coccidian cGMP-dependent protein kinase in motility and invasion

    Helen I Wiersma;Stefan E Galuska;Fiona M Tomley;L.David Sibley

  • Toxoplasma gondii Cyclic GMP-Dependent Kinase: Chemotherapeutic Targeting of an Essential Parasite Protein Kinase

    Robert G. K. Donald;John Allocco;Suresh B. Singh;Bakela Nare

  • Gene knock-outs and allelic replacements in Toxoplasma gondii: HXGPRT as a selectable marker for hit-and-run mutagenesis

    Robert G.K Donald;David S Roos

  • Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.

    C. J. M. Beckers;D. S. Roos;R. G. K. Donald;B. J. Luft

  • Purine salvage pathways in the Apicomplexan parasite Toxoplasma gondii

    Kshitiz Chaudhary;John A. Darling;Leah M. Fohl;William J. Sullivan

  • Anticoccidial kinase inhibitors: identification of protein kinase targets secondary to cGMP-dependent protein kinase.

    Robert G.K. Donald;Tanya Zhong;Helen Wiersma;Bakela Nare

  • Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors

    Annaliesa S. Anderson;Alita A. Miller;Robert G.K. Donald;Ingrid L. Scully

  • Homologous recombination and gene replacement at the dihydrofolate reductase-thymidylate synthase locus in Toxoplasma gondii.

    Robert G.K. Donald;David S. Roos

  • Chemical Genetic Identification of Peptidoglycan Inhibitors Potentiating Carbapenem Activity against Methicillin-Resistant Staphylococcus aureus

    Joann Huber;Robert G.K. Donald;Sang Ho Lee;Lisa Wang Jarantow

  • Changes in the expression of human cell division autoantigen-1 influence Toxoplasma gondii growth and development.

    Jay R Radke;Robert G Donald;Amy Eibs;Maria E Jerome

  • A Staphylococcus aureus Fitness Test Platform for Mechanism-Based Profiling of Antibacterial Compounds

    Robert G.K. Donald;Stephen Skwish;R. Allyn Forsyth;Jennifer W. Anderson

Frequent Co-Authors

Kathrin U. Jansen
Kathrin U. Jansen Pfizer (United States)
Annaliesa S. Anderson
Annaliesa S. Anderson Pfizer (United States)
David S. Roos
David S. Roos University of Pennsylvania
Dennis M. Schmatz
Dennis M. Schmatz MSD (United States)
Sheo B. Singh
Sheo B. Singh MSD (United States)
Boris Striepen
Boris Striepen University of Pennsylvania
Deborah L. Zink
Deborah L. Zink Weizenbaum-Institut
William J. Sullivan
William J. Sullivan Indiana University
Buddy Ullman
Buddy Ullman Oregon Health & Science University
Jessica C. Kissinger
Jessica C. Kissinger University of Georgia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Biology and Biochemistry, there are several online degrees that can expand your career options. Many professionals start with foundational science degrees and then pursue specialized online programs to advance their knowledge or change careers efficiently.

If you’re considering a future in nursing, accelerated options like the rn to bsn programs offer a flexible and efficient path for registered nurses to earn a bachelor’s degree. Those interested in leadership roles in healthcare can benefit from an accelerated healthcare management degree online, which opens doors to high-demand management positions.

Mental health careers are also growing, and nurses can move rapidly into this field through programs such as fast track mental health nursing. For those passionate about wellness and nutrition, earning one of the fastest nutrition degree certifications online can provide new professional opportunities in clinical, community, or corporate health.

Exploring these related degree pathways can help you specialize your skills and meet industry demands quickly—often from the comfort of your own home.

Best Scientists Citing Robert G. K. Donald

Trending Scientists

Recently Published Articles